One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

На Дальнем Востоке стартовала Всероссийская акция тестирования на ВИЧ

14 July 2017 07:33

11 июля во Владивостоке стартовала акция по тестированию на ВИЧ, организованная при поддержке Министерства здравоохранения России и РЖД. Специально оборудованный вагон проследует из столицы Приморья в Санкт-Петербург с 24 остановками в наиболее пораженных ВИЧ-инфекцией регионах. Кроме самого поезда, узнать свой ВИЧ-статус можно будет в зданиях вокзалов.


Как сообщили в региональном Центре СПИД, благодаря акции с начала недели свой статус узнали уже более 1 тыс. жителей и гостей Владивостока. Пока это самый высокий показатель, достигнутый в регионе в рамках подобных мероприятий.

Latest News

The Berlin patient rallies public to support HIV research funding

Timothy Ray Brown remains optimistic that the scientific and medical communities can and will achieve this if properly funded.

19 January 14:55

Fresh approach to tuberculosis vaccine offers better protection

Researchers use a weakened form of cytomegalovirus, or CMV, which infects most people without causing disease. They wove tiny bits of a disease-causing pathogen into the CMV. This re-engineered CMV creates and maintains a high state of immunity against the pathogen in vaccinated ...

19 January 08:46

Researchers Consider Hepatitis C Vertical Transmission Rates

The primary source of HCV infection in children is vertical, or mother-to-child, transmission, which occurs in 5% to 10% of at-risk pregnancies. The majority of at-risk pregnant women with chronic HCV acquired the disease through drug use.

18 January 16:07

New multipurpose device to help prevent HIV and pregnancy

RTI-lead team will develop an implant providing long-acting contraception and HIV prevention--the Subcutaneous Contraceptive and HIV Implant Engineered for Long-Acting Delivery (SCHIELD) device. SCHIELD will offer dual protection and be discrete, simple to administer and ...

18 January 14:40